Antidepressant Selection for Normal Pressure Hydrocephalus-Related Depression
For depression associated with normal pressure hydrocephalus (NPH), use a second-generation antidepressant (SSRI or SNRI) selected based on side effect profile and patient tolerability, while prioritizing definitive treatment of the underlying NPH with CSF shunting, as the depression often improves substantially after shunt surgery.
Primary Treatment Approach
The critical clinical principle here is that depression in NPH is frequently a manifestation of the underlying structural pathology, not a primary psychiatric disorder. Historical case reports demonstrate that NPH can present with prominent psychiatric symptoms including psychotic depression before cognitive decline becomes evident 1, 2. This means your treatment algorithm must address both conditions simultaneously:
Step 1: Confirm NPH Diagnosis and Pursue Definitive Treatment
- NPH patients who undergo shunt surgery show improvement not only in gait, cognition, and urinary symptoms, but also in depression and functional outcomes 3
- 80% of shunt surgery patients demonstrate sustained improvement by the first postoperative visit, with only 6% experiencing serious complications 3
- The depression may resolve or significantly improve with CSF diversion alone, making shunt surgery the definitive treatment
Step 2: Pharmacologic Management of Depression
While pursuing NPH evaluation and treatment, initiate antidepressant therapy using second-generation antidepressants:
Select from SSRIs or SNRIs based on the following considerations 4:
- All second-generation antidepressants show equivalent efficacy for treating major depressive disorder—no clinically significant differences exist between SSRIs, SNRIs, or other second-generation agents 4
- Base your selection on adverse effect profile, not efficacy 4
- Consider that 38% of patients don't respond to initial treatment within 6-12 weeks 4
Specific Medication Considerations:
Avoid paroxetine due to increased risk of sexual dysfunction compared to other SSRIs 4
Consider mirtazapine if rapid onset is desired—it demonstrates faster symptom improvement than fluoxetine, paroxetine, or sertraline, though response rates equalize after 4 weeks 4
Common options include:
- Sertraline, citalopram, escitalopram, fluoxetine (SSRIs)
- Venlafaxine, duloxetine (SNRIs)
- Bupropion (if sexual side effects are a concern, though note slightly increased seizure risk)
Monitoring and Adjustment
- Begin monitoring within 1-2 weeks of initiation 4
- Modify treatment if inadequate response by 6-8 weeks 4
- Continue antidepressant for 4-9 months after satisfactory response for first episode; longer duration for recurrent depression 4
Critical Pitfalls to Avoid
Do not treat depression alone without evaluating for NPH: Depression presenting in midlife with apathy, inattentiveness, and poverty of thought may be NPH, not primary depression 2. Missing this diagnosis leads to needless deterioration of a surgically correctable condition.
Do not assume antidepressants will fully resolve symptoms: One case report showed only "moderately successful" treatment with ECT and pharmacotherapy because the underlying structural problem remained 1
Watch for SSRI-associated increased risk of nonfatal suicide attempts, particularly early in treatment 4
Common discontinuation reasons: Nausea and vomiting are the most frequent causes of stopping second-generation antidepressants 4
The Bottom Line
Treat the NPH definitively with shunt surgery while providing symptomatic relief with second-generation antidepressants selected for tolerability. The depression often improves substantially after CSF diversion, making shunt evaluation and surgery the priority intervention. Choose your antidepressant based on side effect profile rather than efficacy, as all second-generation agents perform equivalently for depression treatment.